Malaysia Grants Conditional Approval for CanSino, J&J COVID-19 Vaccines

Kuala Lumpur, Malaysia’s Health Ministry said on Tuesday it has granted conditional approval for emergency use to the single dose COVID-19 vaccines manufactured by China’s CanSino Biologics and U.S. drugmaker Johnson&Johnson, Reuters reported.

It has also approved the use of the Pfizer-BioNTech vaccine for recipients aged 12 and above, the ministry said in a statement.

Source: Saudi Press Agency